- Home
- ONB vs CORT Comparison
ONB vs CORT Comparison
Compare ONB & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ONB | CORT |
|---|---|---|
| Founded | 1834 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 7.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ONB | CORT |
|---|---|---|
| Price | $22.94 | $88.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | $26.20 | ★ $139.00 |
| AVG Volume (30 Days) | ★ 2.7M | 663.7K |
| Earning Date | 01-20-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | ★ 2.73 | N/A |
| EPS | ★ 1.69 | 0.87 |
| Revenue | ★ $2,110,915,000.00 | $741,172,000.00 |
| Revenue This Year | $45.73 | $23.79 |
| Revenue Next Year | $14.53 | $40.97 |
| P/E Ratio | ★ $13.55 | $99.75 |
| Revenue Growth | ★ 20.70 | 17.92 |
| 52 Week Low | $16.83 | $49.00 |
| 52 Week High | $24.49 | $117.33 |
Technical Indicators
Market Signals| Indicator | ONB | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 63.99 | 68.54 |
| Support Level | $22.18 | $81.31 |
| Resistance Level | $23.55 | $87.19 |
| Average True Range (ATR) | 0.48 | 2.86 |
| MACD | 0.17 | 0.74 |
| Stochastic Oscillator | 76.40 | 93.81 |
Price Performance
Historical ComparisonAbout ONB Old National Bancorp
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.